Traditional Chinese Medicine: A Class of Potentially Reliable Epigenetic Drugs

9Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.

Abstract

Epigenetic modification, especially DNA methylation, plays a nonnegligible role in the occurrence and development of tumors. Increasing studies are indicating that traditional Chinese medicine (TCM) plays a considerable anti-tumor role by regulating the process of DNA methylation modification. Studies on TCM regulating DNA methylation modification mostly focus on the whole genome and abnormal methylation status by active ingredients or single compounds and Chinese herb formula (CHF). The balance and overall concept of TCM theory coincides with the balance of DNA methylation modification in the tumor environment. Regardless of how TCM modulates epigenetics in tumor, it has been shown to bet a class of potentially reliable epigenetic drug.

Cite

CITATION STYLE

APA

Zhu, D., Li, A., Lv, Y., & Fan, Q. (2022, June 14). Traditional Chinese Medicine: A Class of Potentially Reliable Epigenetic Drugs. Frontiers in Pharmacology. Frontiers Media S.A. https://doi.org/10.3389/fphar.2022.907031

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free